Furthermore, a deeper investigation into the biological mechanisms driving the identified late phase predictors, specifically persistent inflammation reflected by elevated CRP, immunosuppression indicated by lymphopenia, and a catabolic state marked by elevated urea, could uncover novel therapeutic targets to alter the clinical course of chronic critical illness after traumatic brain injury. This evidence concerns the gene CRP and lymphopenia.